Literature DB >> 9617593

Practical considerations when treating children with antimicrobials in the outpatient setting.

L N Werk1, H Bauchner.   

Abstract

Over the past decade new antimicrobial agents have been introduced used to treat common paediatric infectious diseases such as acute otitis media and sinusitis. These agents vary with respect to their mechanism of action, dosage and duration of therapy, cost, taste and type of adverse effects. More recently, there has been concern about the overuse of antibiotics and increasing bacterial resistance, particularly Streptococcus pneumoniae, to these agents. Dosage and duration of therapy, cost, taste, and adverse effects play important roles in determining success or failure of antimicrobial medications in paediatric patients. Use of potential alternatives and adjuncts to antimicrobial treatment, such as vaccination, control of environmental risk factors, surgical techniques and alternative medical therapies may also be employed, and the practitioner must ascertain if their paediatric patients are being treated by any of these methods. Rather than listing the therapeutic challenges for all common outpatient paediatric infectious diseases, acute otitis media (accounting for over 50% of the antimicrobial prescriptions dispensed in childhood) is used to illustrate each issue. Clinicians are faced with a growing number of possible antimicrobial choices; concomitantly, there is increasing concern that these agents are overused. When prescribing antimicrobial agents, we need to be familiar with what we can do to optimise the care we provide. By avoiding inappropriate or trivial use of antimicrobials, we can preserve and even strengthen our armamentarium against disease. Simple strategies can improve compliance with therapeutic regimens and improve parental satisfaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617593     DOI: 10.2165/00003495-199855060-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  61 in total

1.  Antibiotic use during the first 200 days of life.

Authors:  G R Bergus; B T Levy; S M Levy; S L Slager; M C Kiritsy
Journal:  Arch Fam Med       Date:  1996-10

2.  Use of antimicrobial agents and drug resistance.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

3.  Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis.

Authors:  C Del Mar; P Glasziou; M Hayem
Journal:  BMJ       Date:  1997-05-24

4.  Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold.

Authors:  A G Mainous; W J Hueston; J R Clark
Journal:  J Fam Pract       Date:  1996-04       Impact factor: 0.493

Review 5.  Otitis media in children.

Authors:  S Berman
Journal:  N Engl J Med       Date:  1995-06-08       Impact factor: 91.245

Review 6.  Assessing the treatment alternatives for acute otitis media.

Authors:  M E Pichichero
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

Review 7.  Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting.

Authors:  M Green; E R Wald
Journal:  Ann Allergy Asthma Immunol       Date:  1996-09       Impact factor: 6.347

8.  Meta-analysis of antibiotics for the treatment of otitis media with effusion.

Authors:  R M Rosenfeld; J C Post
Journal:  Otolaryngol Head Neck Surg       Date:  1992-04       Impact factor: 3.497

9.  Randomized, double blind comparison of brand and generic antibiotic suspensions: I. A study of taste in adults.

Authors:  K M Samulak; G M El-Chaar; L G Rubin
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

10.  Improving pediatricians' compliance-enhancing practices. A randomized trial.

Authors:  L A Maiman; M H Becker; G S Liptak; L F Nazarian; K A Rounds
Journal:  Am J Dis Child       Date:  1988-07
View more
  1 in total

Review 1.  Resistance to Antibiotics and Antifungal Medicinal Products: Can Complementary and Alternative Medicine Help Solve the Problem in Common Infection Diseases? The Introduction of a Dutch Research Consortium.

Authors:  Esther T Kok; Miek C Jong; Barbara Gravendeel; Willem B Van Leeuwen; Erik W Baars
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.